top of page

Biomanufacturing World Summit 2024 - CMC & Quality Partners Round Table

Dec 18, 2024

1 min read

10

132

0

Andrew Jones, Principal, CMC & Quality Partners presented his experience and potential differences between Cell & Gene Therapies Pre-Licensing Inspections, and Biopharmaceutical PAIs. Also presented, were what to expect during and Cell & Gene Therapy PLI.


Andrew's copyrighted presentation is attached below.





Andrew Jones, Principal, CMC & Quality Partners
Andrew Jones, Principal, CMC & Quality Partners

Dec 18, 2024

1 min read

10

132

0

Comments
Share Your ThoughtsBe the first to write a comment.
bottom of page